Colorectal Cancer Clinical Roundup
(Morningstar) June 22, 2020 - Guardant Health, Inc. presents new data at the American Association for Cancer Research (AACR) Virtual Annual Meeting II demonstrating that its LUNAR-2 liquid biopsy is a highly sensitive test that can detect early-stage colorectal cancer (CRC).
(ECOG-ACRIN) June 18, 2020 - Journal of Clinical Oncology publishes results of worldwide InterAAct trial. Less toxicity and overall survival benefit of 7.7 months suggest carboplatin-paclitaxel become the standard treatment for patients with rare anal cancer that is inoperable.
(Chi-Med) June 18, 2020 - Hutchison China MediTech Limited today announces that the U.S. Food and Drug Administration (“FDA”) has granted Fast Track Designation for the development of fruquintinib, for the treatment of patients with metastatic colorectal cancer (“mCRC”) who have been previously treated with fluoropyrimidine-,...
(Physician's Weekly/HealthDay News) June 16, 2020 - For patients with Lynch syndrome, aspirin is associated with a reduced risk for colorectal cancer during long-term follow-up, according to a study published in the June 13 issue of The Lancet.
(Am J Gastroenterol) - 2020-06-03
(Br J Cancer) - 2020-06-03
(Br J Cancer) - 2020-06-08
(Cancer Discov) - 2020-06-08
Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center, and David Ilson, MD, Attending Physician, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College, discuss the progress in colon and rectal cancer presented at ASCO20